Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. Why do VCs in emerging markets take a systems approach? Few local financial intermediaries (including VCs) exist.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

JANUARY 5, 2012

For the past few decades, emerging technologies such as biotechnology, microelectronics, information technology and communications technologies have become central to the socioeconomic development of nations. Yes, they know more about mobile operating systems and mobile payments than they do about farming! The farms are now IT labs.

Information Technology 15

Information Technology Technology Information Trends 15

Harvard Business Review

JUNE 21, 2013

With the war for talent taking place on all fronts, companies must have great talent management practices and systems in place. The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., But too many don''t, according to our research.

Telecommunications 9

Telecommunications Health Care Talent Management Biotechnology 9

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Think of it as a 360-degree/24-7 support system. They’re also sharing risk. The new business model has yet to solidify, and the leaders have yet to emerge. But not for long.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

DECEMBER 30, 2011

That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. Weiss and her team were careful to keep the language of specific belief systems and religions out of PEP.

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

AUGUST 17, 2015

It has tourism—beach and sun and one of the communist world’s last Jurassic political systems—but the real asset is the brains of its people. It could be an ideal location for healthcare organizations, but also for those in applied sciences, biotechnology, and pharmaceuticals. We know two things about biotech in Cuba.

Biotechnology 8

Biotechnology Tourism Human Capital Pharmaceuticals 8

Harvard Business Review

SEPTEMBER 21, 2018

The industry breakdowns were determined using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Harvard Business Review

JUNE 3, 2013

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

MARCH 8, 2013

It is not by accident that the National Institutes of Health spends $31 billion a year on supporting innovation in biotechnology and pharmacology. An even bigger question for the American taxpayer is whether such support leads to a "parasitic" innovation eco-system. Consider Apple.

Venture Capitalist 8

Venture Capitalist Biotechnology Fashion Innovation 8

Harvard Business Review

FEBRUARY 22, 2017

The industry breakdowns were determined using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g.,

Telecommunications 8

Telecommunications Health Care Contingency Plans Biotechnology 8

Harvard Business Review

MARCH 28, 2012

billion to acquire the webOS operating system, Hewlett-Packard discontinued its webOS-based series of smartphones and line of Touchpad tablets — losing its bet on a webOS-everywhere future. By answering these five questions: 1. Have we really seen the future or are we just rolling the dice? Just 13 months after buying Palm for $1.2

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

MARCH 2, 2012

America's higher education system is a magnet for talented leaders from all over the world. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology. The ability to develop global leaders strengthens American companies and the U.S.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

OCTOBER 22, 2013

This industry is fueled by advances in chemistry and biotechnology that allow the use of pharmacological and cosmetic therapies in areas where, earlier, surgical intervention was needed. Everything, everyone, and every system evolves over time. Three major factors drive convergence: technology, competition, and the customer.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

FEBRUARY 16, 2016

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., chemicals, metals & mining, paper & forest products).

Politics 8

Politics Telecommunications Policies Biotechnology 8

Harvard Business Review

JULY 16, 2013

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

Telecommunications 8

Telecommunications Biotechnology Health Care Real Estate 8

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. facility in Cambridge Science Park. Reliance MediaWorks.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

NOVEMBER 29, 2016

They must also have a deep knowledge of the health care system, including its standard practices, in order to understand how the data was originally collected, what biases may exist, and how it can be repurposed to answer clinical research questions.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8

Harvard Business Review

MAY 28, 2013

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., banking & financial services, insurance, real estate); Health Care (e.g.,

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

MARCH 17, 2014

Hospitals, parks, educational systems, sanitation infrastructure, low-income housing — globally, risk-seeking investors build these solutions in partnership with the public sector, which plays its part to adjust incentives, act as a major customer, and provide subsidy where needed. Surely we can do the same for impact investing.

Development 8

Development Microfinance Biotechnology Exit Strategy 8

Harvard Business Review

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. In late 2001 ImClone awaited approval from the Food and Drug Administration (FDA) of its much-heralded new cancer treatment, but unexpectedly the FDA decided to reject the company’s application.

Ethics 8

Ethics Training Biotechnology Morale 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. vincent tsui FOR HBR. Since World War II, the U.S. has been an innovation superpower. Other nations may challenge in one field or another, but no one can match its depth and breadth.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JULY 22, 2015

.” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. Its most successful division, mobile telephony, was looking for a new head of software development at headquarters in Seoul.

Case Study 8

Case Study Career Biotechnology Course 8

Harvard Business Review

SEPTEMBER 11, 2014

For example, a wide variety of clean technologies (including wind, solar, and hydrogen) are vying to power vehicles and cities at the same time that a wide variety of medical technologies (chemical, biotechnological, genomic, and robotic) are being developed to treat diseases. Consider the 2×2 matrix below.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 12, 2012

The West defeated the Soviet Union not through warfare but by maintaining a superior economic system with higher technological standards. trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials.

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

MAY 15, 2015

Mary Shelley told us nothing about the future of biotechnology, but the popularity and plausibility of Frankenstein: The Modern Prometheus tells us a lot about 1818’s fears and aspirations for technology and its relation to society. Taken as a whole, science fiction’s predictions do not outperform random chance.

Class 8

Class Open-book Politics Biotechnology 8

Harvard Business Review

NOVEMBER 9, 2016

Intense biotechnology research and development activities at some of the country’s universities (and their research farms) have raised the complexity and level of the industry’s outputs. Source ideas through foreign direct investment.

Cooper 14

Cooper Long-term Industry Health Care 14

Harvard Business Review

AUGUST 23, 2016

The industry breakout was done using eight major sectors (similar to those in the Global Industry Classification Standard system): Consumer Discretionary (e.g., pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., chemicals, metals & mining, paper & forest products).

Politics 8

Politics Committee Telecommunications Diversity 8